Recursion Pharmaceuticals, Inc.
RXRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001601830
In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.
Superinvestors holding RXRX, Q2 2026
1 superinvestor reports holding Recursion Pharmaceuticals, Inc. on Form 13F, worth $151.7M in total. Weight is Recursion Pharmaceuticals, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | 1.0% | 41,337,632 | $151.7M | Added+2.8% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RXRX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- ARK Invest (+2.8%)
Q1 2026
1 superinvestor holding at quarter end
- Added
- ARK Invest (+7.8%)
Q4 2025
1 superinvestor holding at quarter end
- Added
- ARK Invest (+11.2%)
Q3 2025
1 superinvestor holding at quarter end
- Added
- ARK Invest (+1.7%)
Q2 2025
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−5.2%)
Q1 2025
1 superinvestor holding at quarter end
- Added
- ARK Invest (+7.6%)
Q4 2024
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−1.3%)
Q3 2024
1 superinvestor holding at quarter end
- Added
- ARK Invest (+16.4%)
Q2 2024
1 superinvestor holding at quarter end
- Added
- ARK Invest (+14.5%)
Q1 2024
1 superinvestor holding at quarter end
- Added
- ARK Invest (+19.0%)
- Sold out
- Duquesne Family Office
Q4 2023
2 superinvestors holding at quarter end
- Added
- ARK Invest (+200.4%)
Q3 2023
2 superinvestors holding at quarter end
- Added
- ARK Invest (+45.1%)
- Reduced
- Duquesne Family Office (−34.6%)
Q2 2023
2 superinvestors holding at quarter end
- Added
- ARK Invest (+32.5%)
Q1 2023
2 superinvestors holding at quarter end
- Added
- ARK Invest (+15.4%)
Q4 2022
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−7.7%)
Q3 2022
2 superinvestors holding at quarter end
- Added
- ARK Invest (+23.0%), Duquesne Family Office (+406.5%)
Q2 2022
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−3.4%)
Q1 2022
2 superinvestors holding at quarter end
- Added
- ARK Invest (+26.7%), Duquesne Family Office (+5.3%)
Q4 2021
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−13.9%)
Q3 2021
2 superinvestors holding at quarter end
- New
- Duquesne Family Office
- Added
- ARK Invest (+9.0%)
Q2 2021
1 superinvestor holding at quarter end
- New
- ARK Invest